NASDAQ · GEHC
GE HealthCare Technologies Inc.
$76.42+$0.60 (+0.79%)
GE HealthCare Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.87% below the high.
Loading market information…
OTC · POSC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Positron Corporation’s quoted price sits in the lower half of its reported 52-week range, 37.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Positron Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$76.42+$0.60 (+0.79%)
GE HealthCare Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.87% below the high.
$85.74+$1.81 (+2.16%)
IRadimed Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.54% below the high.
$0.31-$0.02 (-4.82%)
Nano-X Imaging Ltd.’s quoted price sits in the lower half of its reported 52-week range, 93.51% below the high.
$0.14+$0.01 (+6.87%)
Accuray Incorporated’s quoted price sits in the lower half of its reported 52-week range, 90.41% below the high.
$0.15-$0.00 (-1.36%)
Guided Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.15% below the high.
$0.65+$0.02 (+2.94%)
Flyte Aviation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.89% below the high.
$0.06+$0.00 (+5.45%)
Biotricity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.17% below the high.
$0.01$0.00 (0.0%)
Odyssey Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.25% below the high.
